The molecular genetics of hematologic malignancies.
作者信息
Bagg A
机构信息
Pathology Department, Georgetown University Medical Center, Washington, D.C. 20007, USA.
出版信息
Clin Diagn Lab Immunol. 1995 May;2(3):255-62. doi: 10.1128/cdli.2.3.255-262.1995.
Abstract
摘要
相似文献
1
The molecular genetics of hematologic malignancies.血液系统恶性肿瘤的分子遗传学
Clin Diagn Lab Immunol. 1995 May;2(3):255-62. doi: 10.1128/cdli.2.3.255-262.1995.
2
p53 in hematologic malignancies.
Blood. 1994 Oct 15;84(8):2412-21.
3
Antigen receptor genes in hemopoietic malignancies.
Biochim Biophys Acta. 1991 Dec 10;1072(2-3):177-92. doi: 10.1016/0304-419x(91)90013-b.
4
Molecular diagnosis of hematopoietic and lymphoid neoplasms.造血与淋巴组织肿瘤的分子诊断
Hematol Oncol Clin North Am. 2009 Aug;23(4):903-33. doi: 10.1016/j.hoc.2009.04.011.
5
Minimal residual disease in hematologic malignancies.血液系统恶性肿瘤中的微小残留病
Rev Invest Clin. 1994 Apr;Suppl:147-52.
6
7
Medical cytogenetics. IV. Chromosomes in malignancies.
Chic Med Sch Q. 1968;27(4):171-85.
8
Interstitial 9q- deletions in hematologic malignancies.
Cancer Genet Cytogenet. 1984 Aug;12(4):309-19. doi: 10.1016/0165-4608(84)90064-5.
9
[Development of hemomolecular biology in China].
Zhonghua Yi Xue Za Zhi. 1993 Apr;73(4):195-6.
10
[DNA diagnosis in hematological malignancies].[血液系统恶性肿瘤的DNA诊断]
Rinsho Byori. 2001 Mar;Suppl 115:37-44.
本文引用的文献
1
2
Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations.
Blood. 1993 Jun 1;81(11):3097-115.
3
Fluorescence in situ hybridization in leukemia. Applications in diagnosis, subclassification, and monitoring the response to therapy.
Ann N Y Acad Sci. 1993 Mar 20;677:214-24. doi: 10.1111/j.1749-6632.1993.tb38779.x.
4
Current status of cytogenetic research in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病细胞遗传学研究的现状
Blood. 1993 May 1;81(9):2237-51.
5
Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.Mad：一种与Max形成异二聚体的伙伴，可拮抗Myc转录活性。
Cell. 1993 Jan 29;72(2):211-22. doi: 10.1016/0092-8674(93)90661-9.
6
Clinical implications of the p53 tumor-suppressor gene.p53肿瘤抑制基因的临床意义。
N Engl J Med. 1993 Oct 28;329(18):1318-27. doi: 10.1056/NEJM199310283291807.
7
8
p53 mutations are associated with histologic transformation of follicular lymphoma.p53突变与滤泡性淋巴瘤的组织学转化相关。
Blood. 1993 Oct 15;82(8):2289-95.
9
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Oncogene. 1993 Oct;8(10):2741-8.
10
The retinoblastoma gene: role in cell cycle control and cell differentiation.视网膜母细胞瘤基因：在细胞周期调控和细胞分化中的作用。
FASEB J. 1993 Jul;7(10):841-5. doi: 10.1096/fasebj.7.10.8393817.
Zotero 插件